#USA #stem cells #TheWell Bioscience #Monmouth Junction #Xeno-Free

TheWell Bioscience Launches RocketCell™ hMSC Xeno-Free Complete Growth Medium

TheWell Bioscience, recognized as a pioneer in innovative xeno-free cell culture technologies, has unveiled its latest product: the RocketCell™ hMSC Xeno-Free Complete Growth Medium. This advanced growth medium is designed specifically for the robust and reproducible expansion of human mesenchymal stem cells (hMSCs), offering a chemically defined, xeno-free solution that enhances performance in research and various cell therapy manufacturing processes.

Addressing the Needs of Modern Biotechnology

As the landscape of biotechnology evolves, there's an increasing push from regulatory bodies and industry leaders towards standardized, animal-component-free bioprocessing. This shift underscores the growing necessity for scalable and defined MSC culture systems. Traditional approaches involving serum-based MSC culture often introduce variable elements and undefined signaling factors, creating challenges that impede reproducibility and clinical applicability.

RocketCell™ hMSC Xeno-Free Complete Growth Medium directly tackles these issues with its 100% xeno-free, chemically-defined formulation. The benefits are multifaceted:

• - Supports high proliferation rates
• - Enables efficient expansion with low seeding densities
• - Maintains long-term stem cell potency
• - Improves scalability and cost-efficiency

The medium ensures retention of classical hMSC markers and supports differentiated growth into adipogenic, chondrogenic, and osteogenic lineages, illustrating its capability for long-term culture—an essential requirement for regenerative medicine and the development of MSC-based therapeutic solutions.

Industry Impact and Future Prospects

With global projections indicating significant growth in the MSC therapeutics market over the next decade, the demand for reliable expansion platforms is critical to support both translational research pipelines and commercial-scale manufacturing solutions. As John Huang, Ph.D., CEO of TheWell Bioscience, notes, "The industry is rapidly transitioning toward defined, xeno-free bioprocessing systems. RocketCell™ hMSC Complete Growth Medium is not just a high-performance medium; it is integral to our comprehensive, end-to-end xeno-free 3D cell expansion platform."

This platform incorporates advanced defined media, synthetic VitroGel® hydrogels, and automation-compatible VitroPrime™ culture systems. Together, these innovations collectively form a robust infrastructure needed to propel scalable, reproducible, and clinically translatable cell manufacturing processes.

Key Features of RocketCell™

• - Fully Defined, Xeno-Free Formulation: It eliminates any animal-derived inputs, thereby reducing variability, enhancing reproducibility, and increasing readiness for clinical translation.
• - High 3D Culture Capability: This feature supports low-density seeding, upholds high post-passaging viability, and promotes consistent culture renewal for both 2D and 3D MSC workflows.
• - Maintained Potency: Classical hMSC markers and multi-lineage differentiation are preserved, ensuring sustained functionality after long periods of expansion.
• - User-Friendly Workflow: The workflow is optimized for alternate-day feeding, significantly decreasing hands-on time and improving lab efficiency and throughput.

Conclusion

The RocketCell™ hMSC Xeno-Free Complete Growth Medium by TheWell Bioscience sets a new standard in the expansion of human mesenchymal stem cells, supporting everything from early-stage discovery research to advanced preclinical development and cell therapy manufacturing. This launch is not just a product introduction; it represents a transformative advancement in the biotechnology sector, paving the way for future innovations in stem cell research and therapies.

For further information about this revolutionary growth medium, please visit TheWell Bioscience.

About TheWell Bioscience

TheWell Bioscience provides a comprehensive suite of xeno-free solutions for 3D cell models. Their integrated systems eliminate animal-derived variability, advancing the fields of precision medicine, cell therapy, and biomanufacturing.

For media inquiries:
Kyra Baricaua
Phone: 973-855-4955
Email: [email protected]